Clinical Asthma (Record no. 6880)

MARC details
000 -LEADER
fixed length control field 02226nam a22002417a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240305192443.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220603b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 1466585625
International Standard Book Number 9781466585621
040 ## - CATALOGING SOURCE
Transcribing agency dlc
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Jonathan Bernstein
9 (RLIN) 29552
245 ## - TITLE STATEMENT
Title Clinical Asthma
Remainder of title Theory and Practice
250 ## - EDITION STATEMENT
Edition statement illustrated
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. London
Name of publisher, distributor, etc. CRC Press
Date of publication, distribution, etc. 2014
300 ## - PHYSICAL DESCRIPTION
Extent 337 pages
505 ## - FORMATTED CONTENTS NOTE
Formatted contents note Contents:<br/><br/>Diagnosis of Asthma<br/><br/>Asthma Triggers<br/><br/>Asthma Management and Treatments<br/><br/>Asthma and Special Populations<br/><br/>Approach to Asthma Worldwide and in the Primary Care Setting<br/><br/>
520 ## - SUMMARY, ETC.
Summary, etc. Enormous progress in asthma research has been made in the past 50 years, including a greater understanding of its complex pathogenesis and new and more effective therapies. Consequently, the scientific literature has grown vast and can be difficult to integrate. With contributions from a distinguished panel of world-renowned authors, Clinical Asthma
Expansion of summary note Common terms and phrases: activity acute asthma addition adherence adolescents adults agents airway allergen Allergy Clin Immunol anxiety approach assessment associated asthma control cause cells challenge changes Chest childhood chronic clinical common compared considered corticosteroids daily decreased demonstrated device diagnosis disease disorders dose drug early effects emergency eosinophilic et al evidence exacerbations exercise exposure factors flow frequent guidelines hospital identified important improve increased individuals infections inflammation inhaled initial intervention levels limited lung function measures medication obesity older oral outcomes patients Pediatr persistent phenotype physician poor population practice predicted present prevalence primary recent recommended reduced References reported require Respir respiratory response rhinitis risk role sensitivity severe severe asthma significant specific Step studies suggest symptoms systemic Table technique therapy tion treated treatment trial United wheezing
600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME
General subdivision Medical / Pulmonary & Thoracic Medicine
9 (RLIN) 26869
General subdivision Medical › General Medical / General
9 (RLIN) 29553
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 29554
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme ddc
Koha item type E-BOOKS
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection Home library Current library Shelving location Date acquired Total checkouts Full call number Barcode Date last seen Price effective from Koha item type
            MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO   06/01/2022   616 EBS11350 06/03/2022 06/03/2022 E-BOOKS
Catholic University of  Health and Allied Sciences - CUHAS
Directorate of ICT @ 2024